Literature DB >> 32119615

Specialty Substance Use Disorder Treatment Admissions Steadily Increased In The Four Years After Medicaid Expansion.

Brendan Saloner1, Johanna Catherine Maclean2.   

Abstract

The Affordable Care Act's Medicaid expansion provided insurance coverage to many low-income adults with substance use disorders, but it is unclear whether this led to more people receiving treatment. We used the Treatment Episode Data Set and a difference-in-differences approach to compare annual rates of specialty treatment admissions in expansion versus nonexpansion states in the period 2010-17. We found that admissions to treatment steadily increased in the four years after Medicaid expansion, with 36 percent more people entering treatment by the fourth expansion year in expansion states compared to nonexpansion states. Changes were largest for people entering intensive outpatient programs and those seeking medication treatment for opioid use disorder. The share of admissions paid for by Medicaid increased 23 percentage points in expansion states compared to nonexpansion states, largely displacing treatment paid for by state and local governments. The gradual increase in specialty substance use disorder treatment admissions after Medicaid expansion may reflect improving capacity and access to care.

Entities:  

Keywords:  Abuse treatment; Access to care; Addiction; Affordable Care Act; Health conditions; Health policy; Insurance coverage and benefits; Medicaid; Payment; Pharmaceuticals; Specialty care; Substance abuse; Uninsured

Mesh:

Year:  2020        PMID: 32119615      PMCID: PMC7853763          DOI: 10.1377/hlthaff.2019.01428

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  23 in total

1.  Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.

Authors:  Michael T French; Helena J Salomé; Jody L Sindelar; A Thomas McLellan
Journal:  Health Serv Res       Date:  2002-04       Impact factor: 3.402

2.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

3.  Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states.

Authors:  James A Swartz; Susanny J Beltran
Journal:  Addiction       Date:  2019-08-05       Impact factor: 6.526

4.  Reasons for Not Seeking Substance Use Disorder Treatment: Variations by Health Insurance Coverage.

Authors:  Mir M Ali; Judith L Teich; Ryan Mutter
Journal:  J Behav Health Serv Res       Date:  2017-01       Impact factor: 1.505

5.  The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act.

Authors:  Johanna Catherine Maclean; Brendan Saloner
Journal:  J Policy Anal Manage       Date:  2019

6.  The affordable care act and treatment for "substance use disorders:" implications of ending segregated behavioral healthcare.

Authors:  A Thomas McLellan; Abigail Mason Woodworth
Journal:  J Subst Abuse Treat       Date:  2014-02-25

7.  Insurance Financing Increased For Mental Health Conditions But Not For Substance Use Disorders, 1986-2014.

Authors:  Tami L Mark; Tracy Yee; Katharine R Levit; Jessica Camacho-Cook; Eli Cutler; Christopher D Carroll
Journal:  Health Aff (Millwood)       Date:  2016-06-01       Impact factor: 6.301

8.  Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment.

Authors:  Hefei Wen; Jason M Hockenberry; Tyrone F Borders; Benjamin G Druss
Journal:  Med Care       Date:  2017-04       Impact factor: 2.983

9.  Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA.

Authors:  Susan H Busch; Ellen Meara; Haiden A Huskamp; Colleen L Barry
Journal:  Psychiatr Serv       Date:  2013-06       Impact factor: 3.084

10.  Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.

Authors:  Brendan Saloner; Jonathan Levin; Hsien-Yen Chang; Christopher Jones; G Caleb Alexander
Journal:  JAMA Netw Open       Date:  2018-08-03
View more
  9 in total

1.  The effect of Medicaid expansion on state-level utilization of buprenorphine for opioid use disorder in the United States.

Authors:  Hannah K Knudsen; Jeanie Hartman; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2022-01-29       Impact factor: 4.492

2.  Medicaid expansion and opioid overdose mortality among socioeconomically disadvantaged populations in the US: A difference in differences analysis.

Authors:  Umedjon Ibragimov; Russell W Mansfield; Courtney R Yarbrough; Janet R Cummings; Melvin D Livingston; Regine Haardörfer; Stephanie Beane; Monica M Fadanelli; Danielle F Haley; Hannah L F Cooper
Journal:  Drug Alcohol Depend       Date:  2022-02-26       Impact factor: 4.852

3.  Effects of Medicaid expansion on alcohol and opioid treatment admissions in U.S. racial/ethnic groups.

Authors:  Nina Mulia; Camillia K Lui; Kara M K Bensley; Meenakshi S Subbaraman
Journal:  Drug Alcohol Depend       Date:  2021-12-24       Impact factor: 4.852

4.  Insurance expansions and adolescent use of substance use disorder treatment.

Authors:  Sarah Hamersma; Johanna Catherine Maclean
Journal:  Health Serv Res       Date:  2020-11-18       Impact factor: 3.402

5.  Medicaid Expansion Increased Medications For Opioid Use Disorder Among Adults Referred By Criminal Justice Agencies.

Authors:  Utsha G Khatri; Benjamin A Howell; Tyler N A Winkelman
Journal:  Health Aff (Millwood)       Date:  2021-04       Impact factor: 6.301

6.  Identifying pathways to recent non-fatal overdose among people who use opioids non-medically: How do psychological pain and unmet mental health need contribute to overdose risk?

Authors:  Catherine Tomko; Kristin E Schneider; Saba Rouhani; Glenna J Urquhart; Ju Nyeong Park; Miles Morris; Susan G Sherman
Journal:  Addict Behav       Date:  2021-12-20       Impact factor: 4.591

7.  Private health insurance coverage of drug use disorder treatment: 2005-2018.

Authors:  Ramin Mojtabai; Christine Mauro; Melanie M Wall; Colleen L Barry; Mark Olfson
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

8.  Association Between Assistance With Medicaid Enrollment and Use of Health Care After Incarceration Among Adults With a History of Substance Use.

Authors:  Marguerite E Burns; Steven Cook; Lars M Brown; Laura Dague; Steve Tyska; Karla Hernandez Romero; Cici McNamara; Ryan P Westergaard
Journal:  JAMA Netw Open       Date:  2022-01-04

9.  A longitudinal cross-sectional analysis of substance use treatment trends for individuals experiencing homelessness, criminal justice involvement, both, or neither - United States, 2006-2018.

Authors:  Riley D Shearer; Nathan D Shippee; Kathrine Diaz Vickery; Maria A Stevens; Tyler N A Winkelman
Journal:  Lancet Reg Health Am       Date:  2022-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.